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Depletion of Glutathione and enhanced lipid peroxidation in the CSF of Acute
Psychotics following haloperidol administration.
Abstract
Haloperidol administration for 2 weeks results in significant reduction in the concentration of GSH in the
CSF. Concomitantly, the levels of lipid peroxidation products increased as evidenced by increased
malondialdehyde levels. The malondialdehyde levels in the CSF prior to haloparidol administration were
not significantly higher than that seen in CSF from normal controls (data not shown) suggesting that
increased oxidative stress did not exist in these patients prior to haloperidol administration. All the
patients included in the present study were drug naive and hence the changes observed in the glutathione
and malon6ialdehyde levels in the CSF were indeed mediated by haloperidol administration. The only
other medication that was administered namely, anticholinergic drug, trihexyphenidyl is not known to
cause any oxidative stress. The present study thus demonsuates that haloperidol administration results
in significant oxidative stress. The generation of the oxidative stress is probably due to the increased
turnover of dopemine caused by typical neuroleptics. Increased dopamine turnover is also observed in
Parkinson's disease and the combination therapy consisting of antioxidant vitamin E and monoamine
oxidase inhibitor, deprenyl has been shown to offer limited protection against the progression of the
disease (Parkinson Disease Study Group 1989). In the present study, all the 15 patients exhibited
extrapyramidal symptoms although the time of onset, the duration and the severity of the side effects
differed between patients. On the presumption that the oxidative stress generated by haloperidel may
cause extrapyramidal symptoms, the present study in humans taken together with the evidence provided
in our earlier studies on rats (Shivakumar and Ravindranath 1992,1993) may justify experimental
coadministration of antioxidanls (e.g., vitamin E) with typical neuroleptics like haloperidol to prevent the
acute side effects.
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Introduction
The usage of typical ncumleptic drugs has been limited by the side
effects and toxicity produced by them. The major side effects are
the range of extrapyramidal symptoms including neumleptic malignant syndrome and tardive dyskinesia. The pharmacological
action of neumleptics is associated with their antagonist action on
dopamine receptor. The blockade of dopamine receptors by neuroleptics leads to increased turnover of dopamine as demonstrated by
increased levels of the dopamine metabolite, homovanillic acid in
the cerebrospinal fluid (Scatton et al 1977). Dopamine is metabolized by monoamine oxidase (MAO) as given below:
Dopamine + Oxygen + Water MAO:~. Hydrogen Peroxide +
Ammonia + 3,4 Dihydroxy phenylacetaldehyde
Hydrogen peroxide is a potent oxidant and can react with iron
(Fe z*) or copper (Cu 2÷) to form the highly toxic hydroxyl radical.
Reactive oxygen species such as hydrogen peroxide and hydroxyl
r~:rl;,-.21 ~ , t ~-.rt,~neiu,aha suith r,all:,|car r.,-tnetih:~nte :,,~mng t,,,,v;_
dative damage to proteins, lipids, and deoxyribose nucleic acid
(DNA). The hydroxyl radical can set up a chain reaction leading to
peroxidation of lipids thus damaging the integrity of cell membranes (Halliwel11992).
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Acute (Shivakumar and Ravindranath 1992) and chronic (Shivakumar and Ravindranath 1993) ~ n i s t r a t i o n of I,.aloperidol (a
neuroleptic belonging to the class of butyropbenones) to rats resulted in the generation of significant oxidative stress in brain
regions as evidenced by the loss of the nonprotein thiol antioxidant
glutathione (GSH) and increase in the lipid peroxidation product,
malondialdehyde. The depleted GSH is essentially recovered as
pmtein-GSH mixed disulfide and the oxidized GSH (GSSG)
levels were not elevated substantially. Extensive modification of
the protein thiols was also detected, which could be attributed to
the formation of protein glutathione mixed disulfides and protein
mixed disulfides. Because GSH is responsible for the maintenance
of protein thiol homeostasis in the ceil, the depletion of GSH levels
also contributes to the disturbance in the protein thiol homeostasis.
The generation of oxidative stress in humans by halopeddol
administration is yet to be demonstrated although it has been
hypothesized that the toxic side effects seen in man may be due to
the generation of oxidative stress caused by increased dopamine
turnover (Cadet et al 1986). In an earlier study, Pall et al observed
that phenothiazines increased lipid peroxidation in the cerebrospinal fluid (CSF) of a diagnostically heterogeneous group of
patients (Pall et al 1989). Coadrninistration of vitamin E with
haloperidol resulted in some beneficial effect in patients with
tardive dyskinesia (Lohr et al I988). Two recent studies have
reported little or no beneficial effect of antioxidant therapy in
tardive dyskinesia (Shriqui et al, 1991 and Egan et al 1991), however, to our knowledge, no information is available on the antioxidant status following administration of haloperidol.
In the present study, the concentIation of GSH and the lipid
peroxidation product., malondialdehyde were estimated in the CSF
of & ag-naive acute psychotic patients before and after 2 weeks of
haloperidol administration.
0006-3223/94/$07.00
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Figure I. The concentrationof (A) glutathioneand (B) malondialdehyde in the CSF of patients
before and afterhaloperidoladministration.Glutathione levelswere measured in the CSF before
(A) after(&) haloperidol administration.The levels of malondialdehyde were also determined
before (O) and after(O) haloperidoltreatment.

Methods
Patients
lnpatients of both the sexes aged 17-40 years who met the diagnostic criteria for acute and transient psychosis (F23) of the !CD10 (World Health Organization 1990) formed the sample of the
study. Informed consent was obtained from the patients for (!) the
inpatient stay of at least 2 weeks, (2) treatment with haloperidol,
and (3) two lumbar punctures before and after h~operidol administration for 2 weeks. No patient had clinical evidence of nutritional deficiency, ~urological illness, or associated infections.
None of the patients had a history of alcohol or substance abuse
and none had received neuroleptics or electroconvulsive therapy
before. Routine investigations that included blood counts, fasting
blood sugar, serum cholesterol, liver and renal function tests were
normal in all the patients. Similarly, patients had normal blood
vidal test and serological tests for syphilis.
Patients received oral haloperidol (10 rag/day) for a period of 2
weeks. The anticholinergic drug, trihexyphenidyl (2-4 rag/day)
was administered to all the patients only when the patients manifested extrapyramidal symptoms impairing their daily activities.
The anticholinergic drug was introduced at varying time points
during the 2-week period of haloperidol therapy. No other medication was used during the tint 2 weeks of haloperidol treatment.

Assessment
The psychopathology of the patients was rated using the Brief
Psychiatric Rating Scale (BPRS, Overall and Gotham 1962) be-

fore treatment and after ! and 2 weeks of treatment. Before haloperidol administration was started, and after 2 weeks of haloperidol treatment, CSF was collected by lumbar puncture between the
b - L , disc spaces. CSF samples were aliquoted and two aliquots
were frozen immediately and stored at -20°C. GSH levels in the
CSF were estimated using the enzymatic recycfing method (Tietz
1969) and malondialdehyde was estimated as thiobarbituric acid
reactive products (Ohkawa et al 1979). All biochemical analyses
were carried out blind to patient status. One aliquot of the CSF was
used for the estimation of protein, glucose, and cell count, which
was carried out on the same day as the lumbar puncture. Only
patients with normal CSF (as evidenced by normal cell count,
protein, and glucose levels) were included in the study and continued to receive haloperidol for 2 weeks. Thereafter, another lumbar
puncture was performed and the CSF was collected and used as
before. The patient group was comprised of 15 individuals (8
women) with mean age (SD) of 26.7 (6.8) years. The mean (SD)
duration of illness was 11.2 (7) days. Significant reductions in
BPRS scores from a mean (SD) of 37.3 (4.2) to 22.4 (3.2) was
observed at the end of the 2 weeks of treatment.

Results
The GSH levels in the CSF decreased significantly after 2 weeks of
haloperidol administration. The average decrease in GSH levels
was 76% as compared to pretreatment levels. The mean GSH
levels in the CSF were 2.6 (0.7) and 0.6 (0.13) p.moles/100 ml
before and after haloperidol administration, respectively. The de-
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crease in GSH levels was noted in all the patients included in the
study and it varied between 93% to 21% depletion. Concomitant
with the GSH decrease, the CSF malondialdehyde levels (indicative of lipid peroxidation products) i ~
after halolmidol
administration. The average increase was 86% as compared :o
prelreatmont levels. The mean (SEM) malondialdehyde levels
were 20.0 (4.0) and 36.2 (5.5) nmoles of malondialdehyde/100 mi
CSF before and after haloparidol administration. The increase in
malondialdehyde ranged from 105% to 625% of the lnetreatm~nt
levels, In 2 out of the 15 sets of samples analyzed, no increase was
observed in malondialdehyde levels after haloperidol adtMnisuadon (Figure !).

Discussion
Haloperidol administration for 2 weeks results in significant reduction in the concentralion of GSH in the CSF. Concomitantly,
the levels of lipid peroxidation products increased as evidenced by
increased malondialdehyde levels. The mdlondialdehyde levels in
the CSF prior to haloparidol administration were not significantly
higher than that seen in CSF from normal controls (data not
shown) suggesting that increased oxidative stress did not exist in
these patients prior to haloperidol administration. All the patients
included in the presem study were drug n~ive and hence the
changes observed in the glutathione and malon6ialdehyde levels
in the CSF were indeed mediau~tl by haloperidol adminislration.
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The only other medication that was ~
namely,
anticholinergic drug, uihexyphenidyl is not known to ~
a~
oxidative stress.
The present study thus demonsuates that ~
ad~J#~suafion n~mlts in significant oxidative ~ .
The ~
of die
oxidative mess is probably due to the increased turnover of dopemine caused by typical ~ .
Increased depamiee tm~over
is also observed in Parkimon's ~
a~d the combination therapy consisting of an|ioxidant vitamin E and monoamine oxidase
inhibitor, depronyl has been shown to offer ~
against the progression of the disease (Patkinson ~
Study
Group 1989).
In the present study, all the 15 ~
exhibited extrai~ramidal
symptoms although the time of oeset, the duration and the severity
of the side effects differed be~*weenpatients. On the presumption
that the oxidative stress generated by haloperidel may cause extrapyramidal symptoms, the present study in humans taken together
with the evidence provided in our earlier studies on rats (Shivakumar and Ravindranath 1992,1993) may justify experimental coadministration of antioxidanls (e.g., vitamin E) with typical neuroleptics like haloperidol to prevent the acute side effects.
The authors thank Dr. B.R. Shivakumarand Dr. K. Sadashiv PaJ for help
with me experiments.
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